Meprobamate
Back to searchMolecule Structure
Scientific Name
Meprobamate
Description of the Drug
Meprobamate is an anxiolytic drug used for the short-term management of anxiety symptoms.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00371
http://www.drugbank.ca/drugs/DB00371
Brand Name(s)
Amosene, Bamate, Equanil, Mepriam, Meprobamate, Meprospan, Miltown, Neuramate, Tenavoid, Tranmep
Company Owner(s)
Scherer Laboratories Inc, Sun Pharmaceutical Industries Inc, Invagen Pharmaceuticals Inc, Watson Laboratories Inc, Halsey Drug Co Inc, Alra Laboratories Inc, Nexgen Pharma Inc, Mallard Inc, Mylan Pharmaceuticals Inc, Purepac Pharmaceutical Co
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | AGONIST | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL15286 |
PharmGKB | PA450377 |
Human Metabolome Database | HMDB0014515 |
DrugBank | DB00371 |
PubChem: Thomson Pharma | 14822610 |
PubChem | 4064 |
Nikkaji | J4.475J |
EPA CompTox Dashboard | DTXSID3023261 |
DrugCentral | 1704 |
Guide to Pharmacology | 7225 |
rxnorm | MEPROBAMATE |
ChEBI | 6761 |
ZINC | ZINC000001530701 |